<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01053832</url>
  </required_header>
  <id_info>
    <org_study_id>45</org_study_id>
    <nct_id>NCT01053832</nct_id>
  </id_info>
  <brief_title>Ventricular Pace Suppression Study</brief_title>
  <acronym>VpS</acronym>
  <official_title>Ventricular Pace Suppression Study With the EVIA/ENTOVIS DR-T/DR Pacemaker</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <brief_summary>
    <textblock>
      Investigation of the efficacy and safety of the Ventricular Pace Suppression (VpS) algorithm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to investigate the percentage of reduction of ventricular pacing
      using the VpS feature of the EVIA/ENTOVIS pacemaker in a controlled clinical investigation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of right ventricular pacing with the help of the VpS algorithm in the EVIA/ ENTOVIS pacemakers.</measure>
    <time_frame>6-8 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>A Complication free rate &gt;95%, with respect to the VpS feature of the implanted pacemaker.</measure>
    <time_frame>6-8 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Pacemaker Indication</condition>
  <arm_group>
    <arm_group_label>Ventricular Pace Suppression- ON</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ventricular Pace Suppression- OFF</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VpS algorithm in EVIA and ENTOVIS pacemakers</intervention_name>
    <description>For one group of patients, the VpS algorithm will be activated and for the other group, the VpS algorithm will be deactivated until the cross-over, where these conditions will be switched.</description>
    <arm_group_label>Ventricular Pace Suppression- ON</arm_group_label>
    <arm_group_label>Ventricular Pace Suppression- OFF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Paroxysmal AV block and/or Sinus Node Dysfunction

          -  DDD(R)-ADI(R)-Mode (VpS Algorithm) applicability

        Exclusion Criteria:

          -  Permanent AV block III°

          -  Permanent Atrial Fibrillation/ Flutter

          -  Require mode other than DDD(R)-ADI(R) or DDD(R)

          -  Have a life expectancy of less than six months

          -  Expected to receive heart surgery within six months

          -  Enrolled in another cardiac investigation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hendrik Bonnemeier, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinik für Kardiologie und Angiologie, UNIVERSITÄTSKLINIKUM Schleswig-Holstein, Campus Kiel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinikum Coburg gGmbH</name>
      <address>
        <city>Coburg</city>
        <state>Bavaria</state>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abteilung für Elektrophysiologie, Klinik für Kardiologie und Angiologie, UNIVERSITÄTSKLINIKUM Schleswig-Holstein</name>
      <address>
        <city>Kiel</city>
        <state>Schleswig-Holstein</state>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2010</study_first_submitted>
  <study_first_submitted_qc>January 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2010</study_first_posted>
  <last_update_submitted>October 24, 2011</last_update_submitted>
  <last_update_submitted_qc>October 24, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ventricular pace suppression</keyword>
  <keyword>pacemaker</keyword>
  <keyword>efficacy</keyword>
  <keyword>safety</keyword>
  <keyword>support of intrinsic heart rhythm</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

